FMAR
Price
$53.66Alerts
Change
-$0.17 (-0.32%)
Updated
Nov 13, 01:52 PM (EDT)
Net Assets
1.22B
Intraday BUY SELL Signals
XDEC
Price
$44.08Alerts
Change
-$0.08 (-0.18%)
Updated
Nov 13, 01:40 PM (EDT)
Net Assets
208.15M
Intraday BUY SELL Signals
Interact to see
Advertisement

FMAR vs XDEC

FMAR vs XDEC Comparison Chart in %
loading
loading
View a ticker or compare two or three
A.I.Advisor
Oct 21, 2026

Which ETF would AI Choose? FT Vest U.S. Equity Buffer ETF - March (FMAR) vs. FT Vest U.S. Equity Enhance & Moderate Buffer ETF - December (XDEC)

Key Takeaways

  • Both ETFs employ defined-outcome strategies using FLEX Options on the SPDR S&P 500 ETF Trust (SPY) to deliver buffered exposure to large-cap U.S. equities rather than direct stock ownership.
  • FMAR targets a standard buffer against downside losses over its March-to-March outcome period, while XDEC seeks enhanced upside participation capped at a predetermined level alongside a moderate buffer over its December-to-December period.
  • Each fund maintains a 0.85% expense ratio and relies on options-based replication, resulting in low holding counts and synthetic exposure rather than physical replication of the S&P 500 Index.
  • Structural differences in buffer levels and upside participation create distinct risk-reward profiles suited to investors with varying tolerance for volatility within the same broad equity market exposure.
  • Both products reset annually, so investors purchasing shares between reset dates experience adjusted protection and participation levels until the next outcome period begins.
  • Positioned within the defined-outcome category, the ETFs appeal to investors seeking downside mitigation without shifting into fixed-income or alternative asset classes.

Introduction

FMAR and XDEC represent two options-based defined-outcome ETFs from the same issuer that provide structured exposure to the S&P 500 Index. Rather than competing directly through identical mechanics, they offer differentiated risk-management features within the same thematic category. Investors evaluating buffered equity strategies may find value in comparing their distinct buffer designs and upside mechanics when constructing portfolios that balance growth potential with capital preservation during uncertain market cycles.

FT Vest U.S. Equity Buffer ETF - March (FMAR) Overview

FMAR pursues returns that match the price performance of SPY subject to a predefined buffer against losses over a one-year outcome period beginning each March. The fund invests primarily in FLEX Options referencing SPY and operates as an actively managed, non-diversified vehicle. It typically holds a small number of options contracts rather than individual equities. The expense ratio stands at 0.85%. Key distinguishing features include its annual reset schedule and focus on a standard buffer that absorbs a portion of downside moves before investor losses begin.

FT Vest U.S. Equity Enhance & Moderate Buffer ETF - December (XDEC) Overview

XDEC seeks to provide approximately twice the positive price returns of SPY up to a predetermined cap while offering a moderate buffer against losses over its December-to-December outcome period. Like its counterpart, the fund relies on FLEX Options linked to SPY within a defined-outcome framework. Holdings consist primarily of options positions, resulting in minimal direct equity exposure. The expense ratio is 0.85%. Its structure emphasizes enhanced upside participation in exchange for a capped return and a moderate level of downside protection.

Industry and Thematic Backdrop

Both ETFs operate within the defined-outcome segment of the equity ETF market, which has grown in popularity as investors seek tools to navigate equity volatility without fully exiting growth assets. Macroeconomic factors such as interest-rate expectations, corporate earnings trends, and broader equity-market sentiment influence demand for buffered strategies. Regulatory developments around options usage and tax treatment of structured products also shape the category. Sector risks remain concentrated in large-cap U.S. equities, particularly technology and financial services, given the underlying S&P 500 exposure.

Performance and Positioning Comparison

Over recent market cycles, the funds have exhibited different sensitivity to equity-market movements due to their distinct buffer and participation profiles. FMAR’s standard buffer has historically provided more consistent downside moderation during moderate declines, while XDEC’s enhanced-upside design has allowed greater capture of upside moves in favorable periods, albeit subject to its annual cap. Relative positioning reflects trade-offs between protection depth and return enhancement, with both vehicles showing lower volatility than unbuffered S&P 500 exposure in periods of heightened market swings.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening.

Tickeron AI Verdict

Based on structural characteristics, cost efficiency, and diversification through options-based buffering, Tickeron’s AI would currently assign a modest edge to FMAR for investors prioritizing straightforward downside protection within the defined-outcome category. XDEC’s enhanced participation may appeal more to those with higher risk tolerance and a constructive near-term market view. The assessment remains probabilistic and reflects observable design differences rather than forward-looking performance guarantees.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

VS
FMAR vs. XDEC commentary
Nov 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FMAR is a Hold and XDEC is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for FMAR with price predictions
Nov 12, 2026

FMAR's Indicator enters downward trend

The Aroon Indicator for FMAR entered a downward trend on November 12, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 63 similar instances where the Aroon Indicator formed such a pattern. In 53 of the 63 cases the stock moved lower. This puts the odds of a downward move at 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for FMAR moved out of overbought territory on October 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 57 similar instances where the indicator moved out of overbought territory. In 19 of the 57 cases, the stock moved lower in the following days. This puts the odds of a move lower at 33%.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FMAR as a result. In 38 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 51%.

The 10-day moving average for FMAR crossed bearishly below the 50-day moving average on November 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 60%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FMAR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for FMAR just turned positive on November 12, 2026. Looking at past instances where FMAR's MACD turned positive, the stock continued to rise in 36 of 45 cases over the following month. The odds of a continued upward trend are 80%.

FMAR moved above its 50-day moving average on November 11, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where FMAR advanced for three days, in 258 of 391 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

FMAR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

A.I.Advisor
a Summary for XDEC with price predictions
Nov 12, 2026

XDEC in upward trend: price may ascend as a result of having broken its lower Bollinger Band on November 05, 2026

XDEC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 25 of 32 cases where XDEC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 78%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 11, 2026. You may want to consider a long position or call options on XDEC as a result. In 45 of 66 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.

The Moving Average Convergence Divergence (MACD) for XDEC just turned positive on November 12, 2026. Looking at past instances where XDEC's MACD turned positive, the stock continued to rise in 28 of 51 cases over the following month. The odds of a continued upward trend are 55%.

XDEC moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +0.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where XDEC advanced for three days, in 214 of 388 cases, the price rose further within the following month. The odds of a continued upward trend are 55%.

The Aroon Indicator entered an Uptrend today. In 323 of 547 cases where XDEC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.

Bearish Trend Analysis

The 10-day RSI Indicator for XDEC moved out of overbought territory on October 14, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 72 similar instances where the indicator moved out of overbought territory. In 24 of the 72 cases, the stock moved lower in the following days. This puts the odds of a move lower at 33%.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

TECHNICAL ANALYSIS
Technical Analysis
FMARXDEC
RSI
ODDS (%)
Bearish Trend 5 days ago
33%
Bearish Trend 2 days ago
33%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
40%
Bearish Trend 2 days ago
31%
Momentum
ODDS (%)
Bearish Trend 2 days ago
51%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
55%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 5 days ago
66%
Bullish Trend 5 days ago
55%
Declines
ODDS (%)
Bearish Trend 12 days ago
55%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TMCI5.340.28
+5.53%
Treace Medical Concepts
NVGS21.410.35
+1.66%
NAVIGATOR HOLDINGS Ltd
ESNT64.890.07
+0.11%
Essent Group Ltd
MCO506.56-8.37
-1.63%
Moody's Corp
MGX0.71-0.04
-5.59%
Metagenomi Therapeutics Inc.